Literature DB >> 28202495

Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance.

Song-Bai Lin1, Li Zhou2, Zhi-Yong Liang3, Wei-Xun Zhou3, Ye Jin4.   

Abstract

AIM: It has been shown that G-protein-coupled receptor kinase 2 (GRK2) negatively regulates the insulin-like growth factor 1 receptor (IGF1R) signalling pathway in hepatocellular carcinoma (HCC). The aim of this study was to evaluate the clinicopathological and prognostic significance of GRK2 and IGF1R in HCC.
METHODS: Expression of GRK2 and IGF1R was first detected by tissue microarray-based immunohistochemistry in 156 patients with HCC. Staining results, termed the H-score, were then correlated with clinicopathological variables and patient survival. Finally, the prognostic value of GRK2 and IGF1R was validated in the publically available TCGA (The Cancer Genome Atlas) RNA-sequencing database.
RESULTS: The H-score of GRK2 staining (which was significantly lower in tumour than non-tumour tissue) was negatively associated with that of IGF1R with a reverse trend. No clinicopathological significance of the proteins was found except for a relationship between tumoral IGF1R expression and tumour-node-metastasis stage. In univariate analysis, high IGF1R expression predicted poor overall and disease-free survival, whereas GRK2 was not prognostic. In multivariate analysis, IGF1R was significant for overall survival. Furthermore, IGF1R was also of prognostic value in the TCGA database.
CONCLUSIONS: Our data indicate that GRK2 and IGF1R show a negative correlation in HCC. IGF1R could be a potential marker of poor prognosis for this malignancy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  CANCER RESEARCH; HISTOPATHOLOGY; LIVER CANCER; PROTEINS; SURGICAL PATHOLOGY

Mesh:

Substances:

Year:  2017        PMID: 28202495     DOI: 10.1136/jclinpath-2016-203998

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases.

Authors:  Sheila F Faraj; Nilda Gonzalez-Roibon; Enrico Munari; Rajni Sharma; Arthur L Burnett; Antonio L Cubilla; George J Netto; Alcides Chaux
Journal:  Virchows Arch       Date:  2017-03-27       Impact factor: 4.064

2.  G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma.

Authors:  Yunxiu Luo; Ziyi Wang; Shengjun Xiao; Ruirui Li; Xiaoshan Jiang
Journal:  Dis Markers       Date:  2022-06-20       Impact factor: 3.464

3.  MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.

Authors:  Ying Ye; Juhua Zhuang; Guangdong Wang; Saifei He; Suiliang Zhang; Guoyu Wang; Jing Ni; Jiening Wang; Wei Xia
Journal:  Exp Ther Med       Date:  2017-11-08       Impact factor: 2.751

4.  PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility.

Authors:  Hsin-Wei Jen; De-Leung Gu; Yaw-Dong Lang; Yuh-Shan Jou
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

5.  Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma.

Authors:  Jing Sui; Yan Miao; Jiali Han; Hongmei Nan; Bo Shen; Xiaomei Zhang; Yan Zhang; Yuan Wu; Wenjuan Wu; Tong Liu; Siyi Xu; Sheng Yang; Lihong Yin; Yuepu Pu; Geyu Liang
Journal:  Cancer Med       Date:  2018-05-15       Impact factor: 4.452

6.  microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.

Authors:  Lili Lv; Xiaodong Wang; Tonghui Ma
Journal:  Cancer Manag Res       Date:  2019-03-29       Impact factor: 3.989

7.  Long Non-Coding RNA KCNQ1OT1 Promotes Progression of Hepatocellular Carcinoma by miR-148a-3p/IGF1R Axis.

Authors:  Guoping Xu; Yungang Zhu; Huijia Liu; Yingying Liu; Xuening Zhang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 8.  Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma.

Authors:  Kwang-Hoon Chun
Journal:  Pharmaceutics       Date:  2022-06-29       Impact factor: 6.525

9.  NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma.

Authors:  Xiangkun Wang; Chengkun Yang; Xiwen Liao; Chuangye Han; Tingdong Yu; Ketuan Huang; Long Yu; Wei Qin; Guangzhi Zhu; Hao Su; Xiaoguang Liu; Xinping Ye; Bin Chen; Minhao Peng; Tao Peng
Journal:  Cancer Med       Date:  2017-09-29       Impact factor: 4.452

10.  Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.

Authors:  Weiyu Xu; Xuezhu Wang; Xiaoqian Wu; Si Yu; Jianping Xiong; Xinting Sang; Yongchang Zheng; Zhongtao Zhang
Journal:  Aging (Albany NY)       Date:  2020-08-27       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.